ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$396.71
-2.93 (-0.73%)
▼
5d:
+6.38%
30d:
+27.49%
90d:
+18.05%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Jul 16, 2026
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELV shows positive signals but monitor for confirmation. Market pricing in 4.8% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ELV shows positive signals but monitor for confirmation. Market pricing in 4.8% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$467.78
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$290.46
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $396.71, which is considered extended relative to its 30-day fair value range of $317.17 to $378.73. From a valuation perspective, the stock is trading at a premium (Forward PE: 13.6) compared to its historical average (11.8). At these levels, the market is pricing in 4.8% annual earnings growth.
Technical Outlook: Technically, ELV is showing sideways momentum. The price is approaching resistance at $401.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELV is showing sideways momentum. The price is approaching resistance at $401.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$317.17 -
$378.73
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
Protect Your Profits
ELV is technically overbought (RSI 80). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($388.95)
- BULLISH: Expecting earnings turnaround to 4.8% growth with 2.6% revenue growth
Trading Range Analysis
30-Day Trading Range
$317.17 -
$378.73
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$366.95
Resistance Level
$401.13
Current Trend
Sideways
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.57
Wall Street Target
$388.95
(-2.0%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
-16.8%
Profit Margin
2.6%
Valuation Premium vs History
+4.8% premium
PE vs Historical
13.6 vs 11.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.8%
(market-implied from PE analysis)
1-Year Target
$415.75
(+5%)
2-Year Target
$435.71
(+10%)
3-Year Target
$456.62
(+15%)
3-Yr Target (if PE normalizes)
(PE: 14→12)
PE COMPRESSION
$396.93
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 8.6%)
$825.43
(+108%)
Base:
(SPY PE: 13.6, Growth: 8.6%)
$508.38
(+28%)
Bear:
(PE: 11.5, Growth: 8.6%)
$432.12
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 16.18 | Current EPS (TTM): $23.59
Bull Case
$520.23
(+30%)
Analyst growth 23.9%, PE expands to 17.8
Base Case
$472.94
(+18%)
Market implied 23.9%, PE stable at 16.2
Bear Case
$259.59
(-35%)
Severe decline -20.0%, PE contracts to 13.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 14, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Amy W Schulman
SELL
26 shares
2026-03-12
Ro Khanna
BUY
2026-02-24
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$387 | 63 BUY |
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$100 | 55 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 62 BUY |
|
HUM
Humana Inc |
HOLD
26 analysts |
$244 | 57 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$55 | 62 BUY |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
